Osmotica Pharmaceuticals (OSMT) Reports Q3 Loss, Misses Revenue Estimates

Osmotica Pharmaceuticals (OSMT) delivered earnings and revenue surprises of -16.67% and -7.96%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the…